Skip banner links and go to contentU.S. Department of Health & Human Services * National Institutes of Health
National Heart, Lung, and Blood Institute:  Diseases and Conditions Index
Tell us what you think about this site
  Enter keywords to search this site. (Click here for Search Tips)  
U.S. Department of Health & Human Services National Institutes of Health Diseases and Conditions Index NIH Home NHLBI Home About This Site NHLBI Home NHLBI Home Link to Spanish DCI Tell us what you think
 DCI Home: Blood Diseases: Hemochromatosis: Key Points

      Hemochromatosis
Skip navigation and go to content
What Is ...
Other Names
Causes
Who Is At Risk
Signs & Symptoms
Diagnosis
Treatments
Prevention
Living With
Key Points
Links
 

Key Points

  • Hemochromatosis is a disease in which too much iron builds up in your body. Too much iron in your body can lead to organ damage if it is not treated.
  • Hemochromatosis is most often a genetic disease, caused by inheriting a pair of abnormal HFE genes. Other abnormal genes that could cause hemochromatosis are being studied.
  • Not everyone who has the pair of abnormal HFE genes will develop hemochromatosis.
  • "Carriers" are people who have only one abnormal HFE gene. They do not usually develop the disease, but they can pass the abnormal gene on to their children.
  • The signs and symptoms of hemochromatosis do not usually appear until at least age 40 in men and age 50 in women. The disease is more common in men than women.
  • Many of the signs and symptoms of hemochromatosis are similar to the signs and symptoms of other, more common diseases. Examples of early-stage signs and symptoms are fatigue (tiredness), joint pain, and weakness. Examples of mid- and advanced-stage signs and symptoms are arthritis, heart problems, and liver problems.
  • Hemochromatosis is diagnosed based on your medical and family history, current signs and symptoms, and the levels of transferrin saturation and serum ferritin in your blood.
  • Treatment may include periodic therapeutic phlebotomy (repeated blood removal, a process that is much like donating blood), iron chelation therapy (a medicine), changes in the diet, and treatment of disease complications as needed.
  • Frequent therapeutic phlebotomy may be needed at first to get the iron level back to normal. The treatment may then continue, less often, to keep the iron at a normal level.
  • Fatigue is a common side effect of therapeutic phlebotomy, especially during periods of aggressive treatment.
  • If hemochromatosis is found and treated early, before organ damage occurs, complications can be prevented and a normal lifespan is possible.
  • Family members (blood relatives) of people with hemochromatosis should consider having a doctor check their iron levels.

Living WithPrevious   NextLinks


Email this Page Email all Sections Print all Sections Print all Sections of this Topic


Skip bottom navigation and go back to top
Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute
Blood Diseases | Heart and Blood Vessel Diseases | Lung Diseases | Sleep Disorders
NHLBI Privacy Statement | NHLBI Accessibility Policy
NIH Home | NHLBI Home | DCI Home | About DCI | Search
About NHLBI | Contact NHLBI

Note to users of screen readers and other assistive technologies: please report your problems here.